A Clinical Evaluation of an Esterified Hyaluronic Acid Matrix in Burn Patients for STSG

Inclusion Criteria: * Has a wound originating from a thermal or electrical burn * Target burn area is less than 20% of TBSA * Target burn wound is greater than 0.5% of TBSA * Patient has undergone escharectomy procedure or will undergo escharectomy on the target burn and resulting wound will likely need a split thickness skin graft, but wound site is not immediately ready for grafting * For patients with diabetes, an A1C hemoglobin level between 11 percent (taken within 90 days) Exclusion Criteria: * Current active diagnosis of substance abuse, per the Investigator * Patient currently taking non-inhaled corticosteroids * Patient needs or is likely to need negative pressure wound therapy of the target wound after application of Hyalomatrix Wound Device * Patient is pregnant, planning to become pregnant during study period, or breastfeeding * Unstable medical condition as determined by the site investigator * Patients with known sensitivities to hyaluronan, hyaluronan derivatives, silicone, or any other ingredients of the Hyalomatrix Wound Device